🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today's DF/HCC The Leukemia & Lymphoma Society #ConnectScience #Webinar at 12pm: David Tuveson Cold Spring Harbor Laboratory, "Pathways of Progression in #PancreaticCancer" Next wk: M: Douglas Hanahan EPFL Tu: @TothovaLab Dana-Farber Tu: Andy Intlekofer @sloan_kettering Th: Anthony Letai MD PhD The Society for Functional Precision Medicine Dana-Farber

Today's DF/HCC The Leukemia & Lymphoma Society #ConnectScience #Webinar at 12: TALK 1 @TothovaLab: Biology and Therapeutics Targeting of #CohesinMutations in #MyeloidMalignancies TALK 2 Andy Intlekofer @sloan_kettering: Oncogenic Mechanisms and Therapeutic Targeting of 2-Hydroxyglutarate Metabolism

I am so excited that our paper exploring how metabolic dysfunction contributes to T-cell exhaustion is out today in Nature Immunology. A thread (1/X): rdcu.be/b5AAg

Congratulations to ⁦Andy Intlekofer⁩ fellow Zach Epstein-Peterson ⁦(Zach E-P⁩) for receiving the 2020 ⁦AACR⁩ ⁦AstraZeneca⁩ Lymphoma Research Fellowship! Excited to see the impactful discoveries you will make ⁦@sloan_kettering⁩. aacr.org/about-the-aacr…

I am pleased to share our paper out today in Cancer Cell identifying a novel cancer cell state that is central to phenotypic transitions - and that seems to play a key role in tumor progression and drug resistance. cell.com/cancer-cell/fu…

Check out @mluzsoula new paper on metabolic determinants of lipid peroxidation. An equal collaboration between our lab (Ross Weber and Javier Garcia-Bermudez) and The Pratt Group nature.com/articles/s4158…

New Review online! T Nielsen &co discuss how the disease biology of many sarcomas is driven by #chromatin pathway alterations w/ a view to use this knowledge to better develop targeted therapies for patients with #sarcoma. go.nature.com/30Qkylk Cancer at Nature Portfolio #DNAmethylation

Learn more about our #PhD program in #Cancer #Biology and #BiomedicalSciences by joining a virtual information session. Hear from our Deans and students about the innovative program embedded within @sloan_kettering in #NYC. Register on our webpage sloankettering.edu/gerstner

For all aspiring cancer researchers, check out the PhD program GSK Graduate School @sloan_kettering. It’s an amazing and supportive environment to train in!

#CancerCare can’t wait. If you or someone you know has symptoms or has been diagnosed with cancer, please don’t wait. The #cancer experts at Memorial Sloan Kettering are here for you. Connect with an MSK cancer expert. bit.ly/32SFSHX #MSKAlways

Congratulations to my very first graduate student ⁦Sylvia Zohrabian (She/Her)⁩ for receiving the ⁦Department of Defense 🇺🇸 Horizon Award! A welcome piece of good news in a difficult year. ⁦Weill Cornell GSMS⁩ ⁦@sloan_kettering⁩. Meet Our 2021 Fellows... gradschool.weill.cornell.edu/student-experi…

Congrats to Sylvia Zohrabian (She/Her) and Andy Intlekofer ! Weill Cornell GSMS and #WCGSBCMB directors are so pleased ! Yay! Keep the good news coming!

Please read and use our latest work with David Fenyo on agnostic chemical proteomics: Discovery of Protein Modifications Using Differential Tandem Mass Spectrometry Proteomics pubs.acs.org/doi/10.1021/ac…

So proud that the first paper from Vardhana Lab, an equal collaboration with Ronac Mamtani and Alex Huang's lab, is out today in Nature Medicine: rdcu.be/ckYst. I posted a long tweetorial about this study when it was a preprint, but a few additional thoughts:

Excited to share our collaboration w/ Robert K. Bradley demonstrating that pharmacologic modulation of splicing induces immunogenic neoantigens and augments response to checkpoint blockade. Jointly led by LuLab, Emma De Neef, @jdthomaslab. Out today in @Cell: cell.com/cell/fulltext/…